PMID: 25866791 View source Seiwerth S, et al
It has been of particular interest in research models exploring immune response enhancement, antiviral activity, and immune regulation
Officially, the FDA cites: Insufficient large-scale clinical trials Concerns about consistency, sourcing, and manufacturing standards The need to meet formal drug approval requirements Critics argue (fairly) that this system: Favors large pharmaceutical companies Makes it hard to approve naturally occurring peptides Leaves promising, low-risk compounds in regulatory limbo The short version: This FDA restrictive regulatory change of mind wasnt driven by a sudden safety scare, it was driven by regulatory process and economics
Single peptide Dihexa What it supports A cognitive-support peptide studied for memory, learning, and mental sharpness used in functional medicine protocols focused on focus and long-term brain health
Most B12 in the UK is injected into muscle, but the fatty subcutaneous route is a recognised alternative
E., Greenberg R